Aquestive Therapeutics, Inc. Common Stock (NASDAQ: AQST) last traded at $4.81, up 0.63% on the session. The quote above updates while this page is open; the figures below are drawn from Aquestive Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Aquestive Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker AQST. Its market capitalisation is $603.71 million.
Valuation measures for Aquestive Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $603.71M |
|---|---|
| Enterprise value | $693.91M |
| Price / sales | 11.16 |
| Beta | 0.84 |
Trailing-twelve-month figures tagged in Aquestive Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) |
|---|
| $54.09M |
| Net income (TTM) | -$78.23M |
|---|
| EPS (TTM) | -$0.650 |
|---|
| Gross margin | 67.04% |
|---|
| Operating margin | -97.52% |
|---|
| Cash | $98.49M |
|---|
Range and volume for AQST over the past 52 weeks.
| 52-week high | $7.55 |
|---|---|
| 52-week low | $2.93 |
| Volume | 956.8K |
| Average volume | 2.63M |
| Previous close | $4.78 |
Invest a chosen dollar amount in Aquestive Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell AQST.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.